Podcasts about Acute myeloid leukemia

Cancer of the myeloid line of blood cells

  • 169PODCASTS
  • 725EPISODES
  • 58mAVG DURATION
  • 1WEEKLY EPISODE
  • Sep 22, 2022LATEST
Acute myeloid leukemia

POPULARITY

20152016201720182019202020212022

Categories



Best podcasts about Acute myeloid leukemia

Show all podcasts related to acute myeloid leukemia

Latest podcast episodes about Acute myeloid leukemia

Help and Hope Happen Here
Leslee Hacker will talk about her daughter Lauren and her difficult battle with Acute Myeloid Leukemia. Fortunately Lauren has been cancer free for 6 years. Leslee will also discuss her very successful non-profit Lolo's Angels..

Help and Hope Happen Here

Play Episode Listen Later Sep 22, 2022 65:46


Back in 2012 Leslee Hacker's daughter Lauren was diagnosed with Acute Myeloid Leukemia. On today's podcast Leslee will talk about the very difficult treatment that Lauren went through at that time , resulting in her getting into remission for 3 years. Then on the night of Lauren's 14th birthday party in 2016, Leslee received the dreaded call that Lauren had relapsed, this time with a myeloid sarcoma in her leg.After surgery and more chemotherapy , Lauren left the hospital in July of 2016 and has been cancer free for the last 6 years.Leslee will also talk about her non profit Lolo's Angels which in its infancy included a meeting with Taylor Swift and Joe Biden. Her non profit has done a great deal to help Pediatric Cancer patients who have suffered from various forms of this disease. 

What's Cookin' Today on CRN
Bucher Wines & Dairy Farm, The Benefits Of A Fiber Rich Diet, Therapies For Acute Myeloid Leukemia

What's Cookin' Today on CRN

Play Episode Listen Later Sep 12, 2022


Hematologic Oncology Update
Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes – A Review of the 2022 ASCO Annual Meeting and EHA Congress

Hematologic Oncology Update

Play Episode Listen Later Jul 27, 2022 61:14


Featuring perspectives from Dr Richard Stone, moderated by Dr Neil Love. Produced by Research To Practice.

Research To Practice | Oncology Videos
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes – A Review of the 2022 ASCO Annual Meeting and EHA Congress

Research To Practice | Oncology Videos

Play Episode Listen Later Jul 27, 2022 61:14


Featuring perspectives from Dr Richard Stone, including the following topics: Introduction: RATIFY trial in perspective (0:00) Treatment with FLT3 inhibitors (7:00) Anti-CD47 antibody: Magrolimab (23:04) Anti-TIM-3 antibody: Sabatolimab (31:23) CAR T-cell therapy for acute myeloid leukemia (34:53) Targeted therapy with IDH inhibitors (37:31) New myelodysplastic syndromes classification system (41:20) Hypomethylating agents/venetoclax (45:11) CPX-351 (49:14) Other key data sets (50:59) CME information and select publications

Word Traveler Daily Podcast
Undistracted Devotion to Me

Word Traveler Daily Podcast

Play Episode Listen Later Jul 15, 2022 4:40


As many of my listeners know, I lost my wonderful wife, Adonica, to Acute Myeloid Leukemia nearly seven years ago. I could not have then imagined my life without her, and now all I have left are nice pictures and pleasant memories. I miss her and still occasionally shed bitter tears, but I have our two beautiful children who remind me every day of the woman I cherished for twenty years. God has been gracious to me. Many people never find true love. I did once in my life. “But I want you to be free from concern. One who is unmarried is concerned about the things of the Lord, how he may please the Lord; but one who is married is concerned about the things of the world, how he may please his wife, and his interests are divided…. This I say... to promote what is appropriate and to secure undistracted devotion to the Lord,” (1st Corinthians 7.32-34a, 35). But my life is not over. Maybe I will love and be loved again. I hope so. Until then, today is my new opportunity overcome my natural selfishness and learn “to secure undistracted devotion to the Lord.”

Empowered Patient Podcast
Administering CAR-T Cells Post Transplantation to Target Acute Myeloid Leukemia with Dr. Guenther Koehne Baptist Health Miami Cancer Institute

Empowered Patient Podcast

Play Episode Listen Later Jul 15, 2022 17:40


Dr. Guenther Koehne is the Deputy Director and Chief of Blood and Marrow Transplant and Hematologic Oncology at the Baptist Health South Florida Miami Cancer Institute. They are part of a clinical trial for an approach that protects healthy cells from the toxic side-effects of targeted blood cancer treatments with a focus on acute myeloid leukemia (AML). Guenther explains," And then, we have the opportunity to administer medications or CAR-T cells, for example, post transplantation, that are specifically targeting CD33, which then presumably allows us to specifically target residual leukemia cells." "So, my institution, Miami Cancer Institute, and before that, I was at Memorial Sloan Kettering Cancer Center, where I implemented the purification of stem cells from the stem cell product, from the donor stem cell product, allowing to deplete the T cells and other cells that were not necessarily needed for a successful transplant while we have a purified stem cell population. And on this clinical trial, we can now use the purified stem cells and send them to a specified laboratory to silence or down regulate the expression of CD33, using CRISPR technology so that the end product after this step will include a donor-derived stem cell population that is CD33 negative." #MiamiCancerInstitute #VorBio #CellTherapy #BloodCancers #AML #AcuteMyeloidLeukemia #AML #Leukemia #ClinicalTrial #Miami miamicancerinstitute.com Download the transcript here

Empowered Patient Podcast
Administering CAR-T Cells Post Transplantation to Target Acute Myeloid Leukemia with Dr. Guenther Koehne Baptist Health Miami Cancer Institute TRANSCRIPT

Empowered Patient Podcast

Play Episode Listen Later Jul 15, 2022


Dr. Guenther Koehne is the Deputy Director and Chief of Blood and Marrow Transplant and Hematologic Oncology at the Baptist Health South Florida Miami Cancer Institute. They are part of a clinical trial for an approach that protects healthy cells from the toxic side-effects of targeted blood cancer treatments with a focus on acute myeloid leukemia (AML). Guenther explains," And then, we have the opportunity to administer medications or CAR-T cells, for example, post transplantation, that are specifically targeting CD33, which then presumably allows us to specifically target residual leukemia cells." "So, my institution, Miami Cancer Institute, and before that, I was at Memorial Sloan Kettering Cancer Center, where I implemented the purification of stem cells from the stem cell product, from the donor stem cell product, allowing to deplete the T cells and other cells that were not necessarily needed for a successful transplant while we have a purified stem cell population. And on this clinical trial, we can now use the purified stem cells and send them to a specified laboratory to silence or down regulate the expression of CD33, using CRISPR technology so that the end product after this step will include a donor-derived stem cell population that is CD33 negative." #MiamiCancerInstitute #VorBio #CellTherapy #BloodCancers #AML #AcuteMyeloidLeukemia #AML #Leukemia #ClinicalTrial #Miami miamicancerinstitute.com Listen to the podcast here

A Season of Caring Podcast
Tips for Caring from Someone Who Has Been There

A Season of Caring Podcast

Play Episode Listen Later Jul 7, 2022 23:59 Transcription Available


This week, Rayna Neises, your host, speaks with Heather Carter.  In 2015, Heather was diagnosed with Acute Myeloid Leukemia.  During her hospitalization and illness, she began updating people on her status via blogging.  Heather shared her fears, struggles, inspiration, and spiritual observations.  Eventually, she was able to find ways to be grateful for what the disease triggered in her and the blog went from updating people on the health and healing of her body to reflecting on the health and healing of her soul. Heather writes about cancer, addiction, and diseases of the soul like worry, fear, control, comparison, and resentment.  Two books have come from her blog, Soul Selfie, and Soul Selfie: #nofilter.  She shares the following about her season of being cared for:(3:45)  How others react does affect the health as well as the spiritual and emotional wellbeing of the person who is sick.(4:03)  Remember to just be with the person you are caring for.(5:25)  Treat the person regularly and do regular life stuff.(6:30)  Ask them what they want and need.  (9:16)  It is okay to show that you are sad and that you feel sad for the person who is ill.(11:30)  You have to stay in good mental, spiritual, and physical health, or you will not be able to continue to care for the person.(12:04)  Support from a community is critical for the caregiver and the one being cared for.(21:44)  Find Heather's blog posts (sorts available by topic) and links to purchase her books on her website www.heathercarterwrites.com.  

AWESOME People
#25 | Tymaz | Finding HOPE Through MUSIC

AWESOME People

Play Episode Listen Later Jul 5, 2022 38:08


On my most recent birthday, May 31st, I was on a mission to make it special. I decided to do an AWESOME People episode with a real life warrior who has defied all odds. His name is Tymaz (which fittingly means “warrior” in Persian) and he's a 23 year old, 3-time cancer survivor and 2-time bone marrow transfer recipient. At one point he was told he has 6 months to live. At another point he was told he would never walk again. Yet here he is now, standing tall and pursuing his love of music and telling his story through lyrics. Born in Toronto, Canada Tymaz Baghbani is one of the city's most inspirational hip-hop talents. As a youth, he was on track to becoming a professional soccer player - being scouted by Spanish soccer clubs such as Real Madrid. After beating Leukemia three times, it eventually debilitated his ability to walk for five years. That's where his love for battle rapping began. He eventually won a rap battle for King of the Dot while in a wheelchair - making him the first artist to do so. Tymaz has gone on to create his own songs where he dives into his story of recovery and overcoming adversity. His story touched close to home because my father has been stricken with the same form of cancer since 2018 called Acute Myeloid Leukemia. For this reason, I wanted to spend my birthday sharing the story of this strong young man while together, we bring awareness to AML. I dedicate this episode to everyone that is bravely fighting cancer and the loved ones that are by their side showing unconditional love and support every single minute of every single day. It's undoubtedly the hardest thing I've had to go through in my life, so if you're in the same boat, know that I can genuinely relate to the rollercoaster of emotions you're going through. BUT, as my father always passionately says, "mohkam boro jolo!" (move fiercly forward). 0:00 - 0:42 AWESOME People Intro 0:42 - Iman introduces the episode 3:37 - Introduction of Tymaz 4:54 - Tymaz's stor 9:40 - How Tymaz beat cancer 12:12 - Tymaz's love of soccer 14:43 - What music means to Tymaz 15:32 - Tymaz's relationship with his mom 16:48 - Finding hope through music 20:45 - Tymaz promos 22:00 - The Sick Kids foundation 23:34 - Advice for sick children and their families 27:27 - Tymaz's current projects 33:47 - Tymaz's five year plan 36:25 - Tymaz's closing message Keep the faith, Iman Follow us on Instagram: @imanhuschmand @tymaz9 @letsuniteandconquer Welcome to the conversation. Welcome to AWESOME people.

Mornings with Jeff & Rebecca
Miracles Still Happen Every Day

Mornings with Jeff & Rebecca

Play Episode Listen Later Jun 30, 2022 1:47


A pastor named Dave had been fighting Acute Myeloid Leukemia for a while and all signs were pointing up that he was going to beat this but then something tragic happened. His appendix ended up rupturing and because of that, he was in some real trouble. The cancer had destroyed all of his white blood cells which prevented him from fighting off any sort of infection.But just as the doctors and members of his church were losing hope of him beating this, one lady at his church said something that stuck with him. 

The Fellow on Call
Episode 019: Heme/Onc Emergencies, Pt. 8: APL

The Fellow on Call

Play Episode Listen Later Jun 22, 2022


Emergencies happen in hematology and oncology. This is a fact. But how do we manage these emergencies? Look no further. In this episode, we'll talk about one of the key hematologic malignancies that you'll encounter as a fellow, one that requires immediate action to reduce mortality: acute promyelocytic leukemia (APL or APML)- Acute Promyelocytic leukemia (APL or APML):**Stay tuned for our upcoming “part two” and “chemotherapy basics” episodes for more information on non-acute management of this disease**APL is a true hematologic emergency! Although this is a very curable form of leukemia, it is associated with high rates of severe DIC and high mortality in the period immediately following diagnosis***Untreated, can see pulmonary or cerebrovascular hemorrhage in up to 40% of patients***10-20% incidence of hemorrhage-related mortality in the initial period***Statistically significant increase in mortality at 30 days with just a 12-hour delay in initial hematologist consultation- Disease basics:** Rare subtype of AML(

Research To Practice | Oncology Videos
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting

Research To Practice | Oncology Videos

Play Episode Listen Later Jun 20, 2022 63:08


Featuring perspectives from Drs Courtney DiNardo, Michael Savona and Eunice Wang, including the following topics: Introduction (0:00) Selection of therapy for older and younger patients with acute myeloid leukemia (AML) (2:05) Therapy for patients with AML with targetable mutations (33:42) Current and future management of myelodysplastic syndromes (49:04) CME information and select publications

FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)
FDA D.I.S.C.O. Burst Edition: FDA approval of Tibsovo (ivosidenib) in combination with azacitidine for newly diagnosed acute myeloid leukemia with a susceptible IDH1 mutation, as detected by an FDA-approved test in adults 75 years or older, or who have co

FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)

Play Episode Listen Later Jun 17, 2022 4:00


Listen to a soundcast of the 05/25/022, FDA approval of Tibsovo (ivosidenib) for newly diagnosed acute myeloid leukemia with a susceptible IDH1 mutation, as detected by an FDA-approved test in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.

Research To Practice | Oncology Videos
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress

Research To Practice | Oncology Videos

Play Episode Listen Later Jun 10, 2022 63:29


Featuring perspectives from Ms Ilene Galinsky and Dr Eunice Wang, including the following topics: Introduction (0:00) Younger patients with acute myeloid leukemia (AML) (2:11) Older patients with AML (34:45) Treatment for myelodysplastic syndromes (49:57) NCPD information and select publications

TechNation Radio Podcast
Episode 22-24 Biotech Beyond Covid

TechNation Radio Podcast

Play Episode Listen Later Jun 9, 2022 59:00


On this week's Tech Nation, Moira speaks with Dr. Robert Ang, the President & CEO of Vor Biopharma about its approach to Acute Myeloid Leukemia, also known as AML. Then Dr. Nik Sopko, the Chief Scientific Officer of PolarityTE talks about their design for wound healing. Their first treatment candidate is diabetic foot ulcers. And Dr. Eric Vivier from Innate Pharma in Marseilles tells us about the next wave of immunotherapy treatments – harnessing Natural Killer cells.

TechNation Radio Podcast
Episode 473: Episode 22-24 Biotech Beyond Covid

TechNation Radio Podcast

Play Episode Listen Later Jun 9, 2022 59:00


On this week's Tech Nation, Moira speaks with Dr. Robert Ang, the President & CEO of Vor Biopharma about its approach to Acute Myeloid Leukemia, also known as AML. Then Dr. Nik Sopko, the Chief Scientific Officer of PolarityTE talks about their design for wound healing. Their first treatment candidate is diabetic foot ulcers. And Dr. Eric Vivier from Innate Pharma in Marseilles tells us about the next wave of immunotherapy treatments – harnessing Natural Killer cells.

Hematologic Oncology Update
Striving for Consensus on the Management of Secondary Acute Myeloid Leukemia

Hematologic Oncology Update

Play Episode Listen Later May 31, 2022 126:48


Featuring a discussion on the management of acute myeloid leukemia with Drs Naval Daver, Stephen Strickland, Geoffrey Uy and Eunice Wang, moderated by Dr Neil Love.

Research To Practice | Oncology Videos
Acute Myeloid Leukemia | Striving for Consensus on the Management of Secondary Acute Myeloid Leukemia

Research To Practice | Oncology Videos

Play Episode Listen Later May 31, 2022 138:34


A clinical investigator think tank and enduring multimedia activity with Drs Naval Daver, Stephen Strickland, Geoffrey Uy and Eunice Wang, including the following topics: Introduction to therapy-related Acute Myeloid Leukemia (AML) (0:00) Treatment of AML evolving from prior MDS (12:27) Treatment of secondary AML in a patient ineligible for intensive therapy (29:41) Treatment for a patient with secondary AML with an IDH mutation (40:56) Long-term follow-up of CPX- 351 in patients with secondary AML (46:27) Potential role of venetoclax in combination with intensive chemotherapy regimens (52:54) Treatment for younger patients with secondary AML (58:46) Treatment of secondary AML with a FLT3 mutation (1:03:59) Data with CPX-351 in combination with targeted agents (1:08:30) Refractory disease versus differentiation syndrome from IDH inhibitors (1:19:20) Emerging data with menin inhibitors (1:28:13) Treatment of secondary AML evolving from prior MPN (1:31:52) Treatment of secondary AML with core binding factor (1:53:14) CME information and select publications

The ASCO Post Podcast
FDA Approval for Newly Diagnosed Acute Myeloid Leukemia

The ASCO Post Podcast

Play Episode Listen Later May 27, 2022 10:28


This week, we're covering the FDA approval of a doublet therapy in certain populations of patients with newly diagnosed acute myeloid leukemia. Then we'll hear about a comparison study of treatments for patients with metastatic breast cancer and brain metastases.Coverage of stories discussed this week on ascopost.com:FDA Approves Ivosidenib/Azacitidine for Certain Patients With Newly Diagnosed AMLEtirinotecan Pegol vs Physician's Choice of Chemotherapy for Patients With Metastatic Breast Cancer and Brain MetastasesTo listen to more podcasts from ASCO, visit asco.org/podcasts.

Two Onc Docs
Acute Myeloid Leukemia (AML)

Two Onc Docs

Play Episode Listen Later May 9, 2022 15:18


Today's episode is all about AML (acute myeloid leukemia), including the usual presentation, diagnostic work-up, risk stratification (and tricks to remember these), molecular testing, and treatment options for first-line, as well as relapsed/refractory disease.

Help and Hope Happen Here
Ashley Haseotes will talk about her innovative and highly successful non profit ONE MISSION which she started after seeing her son Nicholas hospitalized for 188 days during his Leukemia battle. The good news is that he is now a teenager and thriving.

Help and Hope Happen Here

Play Episode Listen Later May 2, 2022 55:44


After watching her son Nicholas spend  188 days in the hospital with Acute Myeloid Leukemia,   Asley Haseotes decided to start a non profit to help future Pediatric Cancer patients be able to have some enjoyment during their mostly difficult hospital stays. She and her husband Ari named this non profit ONE MISSION and it is made up of many creative and successful programs which have brought smiles to the faces of these kids. This non profit has raised 14.6 million dollars and has helped to support 36,000 kids in hospital settings around the Greater Boston area. Her son Nicholas is well past his original diagnosis of over 10 years ago and is thriving as he is in his teenage years.

BrandBuilders
245: Stephanie Perri

BrandBuilders

Play Episode Listen Later Apr 28, 2022 52:32


Cancer research is a big deal to us here at The Dunstan Group, because of how cancer has touched our lives personally. Our next guest on the BrandBuilders Podcast has also seen the devastation of cancer – she lost her husband, Chris, to Acute Myeloid Leukemia a little over a year ago in January 2021. Since then, Stephanie Perri has made up her mind to fight back, just like her husband Chris did and has put her hat in the running for the Leukemia & Lymphoma Society Woman of the Year. Stephanie joins us today with Dr. Josh Zeidner, chief of leukemia research at UNC, and Laura Blanchard, who is a PA in hematology. Vote for Stephanie here: https://pages.lls.org/mwoy/nc/triangle22/sperri

Cleveland Clinic Cancer Advances
Less-Intensive Therapies for Acute Myeloid Leukemia Tied to Higher Mortality Risks

Cleveland Clinic Cancer Advances

Play Episode Listen Later Apr 14, 2022 23:18


Aaron Gerds, MD, MS, hematologist in Cleveland Clinic Cancer Center's Leukemia & Myeloid Disorders Program joins the Cancer Advances podcast to talk about acute myeloid leukemia. Listen as Dr. Gerds discusses less intensive therapies for acute myeloid leukemia and their impact on mortality.

DocWorking: The Whole Physician Podcast
159: Life as a Physician Leader in the Pharmaceutical Industry with Dr. Neil Sankar

DocWorking: The Whole Physician Podcast

Play Episode Listen Later Apr 4, 2022 25:08


“You know, after the drug gets approved, it's a feather in your cap. You have been part of an NDA, that's great. Your value goes up. But after that, what do you do?” -Neil Sankar MD, MPH In this episode, DocWorking Founder and CEO, Dr. Jen Barna welcomes Dr. Neil Sankar. Dr. Sankar is President and Chief Medical Officer of SwanBio, LLC, a business development consultancy firm that facilitates the translation of scientific discoveries into cancer therapeutics. Dr. Sankar has over 16 years of experience in life sciences clinical development, pipeline strategy, clinical safety, and pharmacovigilance. Dr. Sankar shares his wealth of experience in the pharmaceutical industry with the DocWorking audience. He tells us about his journey, his tips for those wanting to get into pharmaceuticals and how he finds time to relax. If you are thinking about getting into the pharmaceutical industry, you will find this episode extremely helpful!   Neil Sankar received his MD degree from Bangalore University and internal medicine residency from University of West indies, Kingston, Jamaica and trained in the UK and the Caribbeans. He holds a postgraduate degree in public health from Queensland University in Australia.   Dr. Sankar got his training in clinical research and tumor biology from NCI Bethesda Maryland and since has held Clinical Development positions within leading Biotech/Pharma including Genentech, Medimmune, Pharmacyclics, FiveprimeTherapeutics, Portola, Loxo Oncology, Otsuka Pharmaceuticals, Elevar Therapeutics, Boston Biomedical, Effector Therapeutics and  Rhizen Pharmaceuticals to name a few.   Dr. Sankar is President and Chief Medical Officer of SwanBio, LLC, a business development consultancy firm that facilitates the translation of scientific discoveries into cancer therapeutics. Dr. Sankar has over 16 years of experience in life sciences clinical development, pipeline strategy, clinical safety, and pharmacovigilance. He has extensive experience in the application of US Food and Drug Administration regulations and the Good Clinical Practice guidelines set forth by the International Council on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. He has acted as Medical lead in numerous phase I, II and III clinical trials in the therapeutic area of oncology ranging from solid tumors, connective tissue tumors to hematological malignancies including, CLL/SLL, B cell lymphomas, T cell Lymphomas, Acute Myeloid Leukemia and Hodgkins Lymphoma. He is an expert in providing global clinical development and regulatory strategies for therapeutic drugs and was instrumental in filing the New Drug Applications for the antibody-drug conjugate in Metastatic Breast cancer and the Bruton tyrosine kinase inhibitor in Mantle cell Lymphoma. Dr. Sankar has extensive experience in designing and deploying data capture tools that evaluate the efficacy and safety of clinical trials. He also has extensive experience as a member of drug safety committees and advisory boards of few companies including Leukemia Therapeutics and iNDX Technology. Dr Sankar has led or has been part of FDA/Regulatory Authority discussions for various companies pursuing IND and NDA applications including Pre-IND and Pre-NDA F2F meetings.   Dr. Sankar is an active member of the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), the European Hematology Association (EHA , Drug information Association (DIA) , European Society of Clinical Oncology (ESMO), American Association for Cancer Research (AACR), Enterprising Pharmaceutical Professionals from the Indian Sub-Continent (EPPIC GLOBAL), Connective Tissue Oncology Society (CTOS), IACA and TiE Silicon Valley. Find full transcripts of DocWorking: The Whole Physician Podcast episodes on the DocWorking Blog  DocWorking empowers physicians and entire health care teams to get on the path to achieving their dreams, both in and outside of work, with programs designed to help you maximize life with minimal time.   Are you a physician who would like to tell your story? Please email Amanda, our producer, at Amanda@docworking.com to be considered.   And if you like our podcast and would like to subscribe and leave us a 5 star review, we would be extremely grateful!   We're everywhere you like to get your podcasts! Apple iTunes, Spotify, iHeart Radio, Google, Pandora, Stitcher, PlayerFM, ListenNotes, Amazon, YouTube, Podbean   You can also find us on Instagram, Facebook, LinkedIn and Twitter.    Some links in our blogs and show notes are affiliate links, and purchases made via those links may result in payments to DocWorking. These help toward our production costs. Thank you for supporting DocWorking: The Whole Physician Podcast!   Occasionally, we discuss financial and legal topics. We are not financial or legal professionals. Please consult a licensed professional for financial or legal advice regarding your specific situation.   Podcast produced by: Amanda Taran

Research To Practice | Oncology Videos
Acute Myeloid Leukemia| Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia — Part 5

Research To Practice | Oncology Videos

Play Episode Listen Later Mar 25, 2022 60:51


Featuring perspectives from Dr Rebecca Olin, including the following topics: Introduction: Journal Club with Rebecca L Olin, MD, MSCE — Evaluation of the older patient with acute myeloid leukemia (AML) (0:00) Case: A woman in her late 80s with transfusion-dependent AML secondary to myelodysplastic syndrome — Raman Sood, MD (7:52) Case: A frail man in his mid 70s with newly diagnosed poor-risk AML with FLT3-ITD and IDH1 mutations — Amany R Keruakous, MD, MS (12:46) Case: A woman in her late 60s with relapsed AML and a FLT3-ITD mutation — Prashant Sharma, MD (18:23) Case: A man in his late 50s with AML receives 7 + 3 induction prior to discovery of complex cytogenetics — Rachel J Cook, MD (22:04) ASH 2021 review — Part 1 (25:07) Case: A man in his early 70s with relapsed AML and an IDH2 mutation — Erik J Rupard, MD (29:13) Case: A man in his late 50s with therapy-related AML and an IDH2 mutation — Bhavana (Tina) Bhatnagar, DO (32:28) Case: A woman in her mid 40s with newly diagnosed poor-risk AML and an ejection fraction of 35% — Dr Keruakous (32:28) ASH 2021 review — Part 2 (39:28) Faculty survey (58:32) CME information and select publications

Hematologic Oncology Update
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia — Part 5 of a 5-Part Series

Hematologic Oncology Update

Play Episode Listen Later Mar 25, 2022 60:50


Featuring a discussion on the treatment of acute myeloid leukemia with Dr Rebecca Olin, moderated by Dr Neil Love.

Pruning To Prosper - Clutter, Money, Meals and Mindset for the Catholic Mom
Episode 4. [Faith] Part 2 of 2. God's Plan Is Better Than Our Plan, The Day The Plan Was Put Into Action Part 2

Pruning To Prosper - Clutter, Money, Meals and Mindset for the Catholic Mom

Play Episode Listen Later Mar 23, 2022 23:13


This episode is the continuation of part 1.  With our newborn baby diagnosed with Acute Myeloid Leukemia, we were transferred from our local hospital to a hospital over an hour from our home.  In this episode I share how my biggest worry other than my son's health was already taken care of by God.  He knows our worries and when we step into our divine plan, He takes care of all the details.  Hear how these three miracles worked together for the greater good.     Proverbs 3:5-6   email: tightshipmama@gmail.com Facebook: https://www.facebook.com/tightshipmama YouTube: https://www.youtube.com/channel/UCyBOLMzUaXPRTy59xCxr76g

Pruning To Prosper - Clutter, Money, Meals and Mindset for the Catholic Mom
Episode 3. [Faith] Part 1 of 2. God's Plan Is Better Than Our Plan, The Day The Plan Was Put Into Action, Part 1

Pruning To Prosper - Clutter, Money, Meals and Mindset for the Catholic Mom

Play Episode Listen Later Mar 23, 2022 16:23


God has a plan for each of us.  I knew from a very young age that I was going to have 5 kids, marry the boy of my dreams, that our marriage would be very special and that we would go through something big together.  I never knew what this "big" thing was but I knew it would be part of what we were called to do.  When our second child was born with Acute Myeloid Leukemia, I knew this part of God's plan for our life had begun.  This is part one of two where I share the story of our son's birth and diagnosis. As our story unfolds you will begin to see just how much God has thought through all the details.  I'll share some of the miracles we experienced and as this podcast grows in the years to come, I will revisit this story often.  Being tasked as Teddy's mom is one of the greatest blessings I have ever been given.  While God's plan isn't always what we would have chosen, the peace that transcends all human understanding when you surrender, is worth it. email: tightshipmama@gmail.com Facebook: https://www.facebook.com/tightshipmama YouTube: https://www.youtube.com/channel/UCyBOLMzUaXPRTy59xCxr76g

Cancer Actually F***ing Sucks
Season 2, Episode 3: Rian Harvey - 2X Acute Myeloid Leukemia Survivor, Founder of The L Card, & Finding The Things That Make Your Happy

Cancer Actually F***ing Sucks

Play Episode Listen Later Mar 22, 2022 61:36


This week's episode we're talking to Rian Harvey, who was diagnosed with Acute Myeloid Leukemia (AML) at age 14 in 2013. He first found out something was wrong when he felt that he was becoming less active and social in his teenage years and was having horrible pain in his leg. Rian explains how he finally found out what was going on in his body and his journey to diagnosis, dealing with an intense and risky surgery, his journey through chemo, going through cancer as a teenager, and how he hadn't really processed his cancer experience until the pandemic 7 years later when life slowed down. Rian also touches on how him starting to process his cancer experience caused him to want to give back to the cancer community in order to help other people feel less alone and remind them that they can get through anything. He also started The L Card, an online community and podcast to connect cancer patients and survivors with one another. Rian is truly amazing, we teared up as he was speaking with us and we can't wait for you all to listen and be inspired by his story! You can follow Rian on Instagram @thelcard_rh and check out his podcast The L Card anywhere you listen to podcasts. Follow us and keep up with our guests on Instagram @canceractuallysuckspod, @shancury and @cancersurvivor_nutritioncoach!

Hematologic Oncology Update
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia — Part 4 of a 5-Part Series

Hematologic Oncology Update

Play Episode Listen Later Mar 15, 2022 61:35


Featuring a discussion on the treatment of acute myeloid leukemia with Dr Amir Fathi, moderated by Dr Neil Love.

Research To Practice | Oncology Videos
Acute Myeloid Leukemia | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia — Part 4

Research To Practice | Oncology Videos

Play Episode Listen Later Mar 15, 2022 61:36


Featuring perspectives from Dr Amir Fathi, including the following topics: Introduction: Differentiation Syndrome (0:00) Case: A woman in her late 70s who received decitabine/venetoclax for acute myeloid leukemia (AML) — Bhavana (Tina) Bhatnagar, DO (14:24) Case: A man in his early 30s with AML harboring a FLT3-ITD mutation with an allelic ratio of 0.6 and NPM1 and IDH2 mutations — Jeanne Palmer, MD (24:04) Case: A woman in her late 70s with ovarian cancer who develops AML with a TP53 mutation and a complex karyotype — Dr Bhatnagar (33:37) Case: A woman in her mid-30s with inversion 16 AML — Dr Palmer (46:33) Faculty Survey (50:05) Journal Club with Amir Fathi, MD (57:25) CME information and select publications